Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boyd

Showing results (1111-1120 of 1,228) with videos related to

Pageof 123
Sort By:
Genes, Chromosomes & Cancer|October 1, 2011
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapyKevin D Boyd, Fiona M Ross, William J Tapper, et al.
Medical Mycology|February 24, 2001
Candida albicans: adherence, signaling and virulenceR Calderone, S Suzuki, R Cannon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoiresChen Wang, Yi Liu, Lan T Xu, et al.
Cell Host & Microbe|April 19, 2025
Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccineYupeng Feng, Sanne E de Jong, Ana Paula B N Oliveira, et al.
International Journal of Circumpolar Health|July 10, 2024
Updated review on contaminant communication experiences in the circumpolar ArcticEva M Krümmel, Amanda D Boyd, Danielle Brandow, et al.
Nature|June 22, 2017
Identifying specificity groups in the T cell receptor repertoireJacob Glanville, Huang Huang, Allison Nau, et al.
Communications Medicine|April 29, 2025
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D Boyd, Shixia Wang, Hsiao-Wen Lin, et al.
Science Translational Medicine|February 18, 2010
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencingScott D Boyd, Eleanor L Marshall, Jason D Merker, et al.
Eclinicalmedicine|August 9, 2023
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialJohn R Jones, David A Cairns, Tom Menzies, et al.
Leukemia|August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trialK D Boyd, F M Ross, L Chiecchio, et al.
Pageof 123

Showing results (1111-1120 of 1,228) with videos related to

Sort By:
Pageof 123
Genes, Chromosomes & Cancer|October 1, 2011
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapyKevin D Boyd, Fiona M Ross, William J Tapper, et al.
Medical Mycology|February 24, 2001
Candida albicans: adherence, signaling and virulenceR Calderone, S Suzuki, R Cannon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoiresChen Wang, Yi Liu, Lan T Xu, et al.
Cell Host & Microbe|April 19, 2025
Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccineYupeng Feng, Sanne E de Jong, Ana Paula B N Oliveira, et al.
International Journal of Circumpolar Health|July 10, 2024
Updated review on contaminant communication experiences in the circumpolar ArcticEva M Krümmel, Amanda D Boyd, Danielle Brandow, et al.
Nature|June 22, 2017
Identifying specificity groups in the T cell receptor repertoireJacob Glanville, Huang Huang, Allison Nau, et al.
Communications Medicine|April 29, 2025
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D Boyd, Shixia Wang, Hsiao-Wen Lin, et al.
Science Translational Medicine|February 18, 2010
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencingScott D Boyd, Eleanor L Marshall, Jason D Merker, et al.
Eclinicalmedicine|August 9, 2023
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialJohn R Jones, David A Cairns, Tom Menzies, et al.
Leukemia|August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trialK D Boyd, F M Ross, L Chiecchio, et al.
Pageof 123